1. A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma. (5th January 2016) Authors: Armand, Philippe; Redd, Robert; Bsat, Jad; Mayuram, Sangeetha; Giardino, Angela; Fisher, David C.; LaCasce, Ann S.; Jacobson, Caron; Davids, Matthew S.; Brown, Jennifer R.; Weng, Li; Wilkins, Jennifer; Faham, Malek; Freedman, Arnold S.; Joyce, Robin; Jacobsen, Eric D. Journal: British journal of haematology Issue: Volume 173:Number 1(2016) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. Issue 8 (August 2019) Authors: Davids, Matthew S; Brander, Danielle M; Kim, Haesook T; Tyekucheva, Svitlana; Bsat, Jad; Savell, Alexandra; Hellman, Jeffrey M; Bazemore, Josie; Francoeur, Karen; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A; Armand, Philippe; Ng, Samuel; Crombie, Jennifer; LaCasce, Ann S; A... Journal: Lancet Issue: Volume 6:Issue 8(2019) Page Start: e419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗